Evidence map›Paper›PMID 36597074›Full record

ArticleBMC infectious diseases2023

European Cohorts of patients and schools to Advance Response to Epidemics (EuCARE): a cluster randomised interventional and observational study protocol to investigate the relationship between schools and SARS-CoV-2 infection.

Sara Raimondi, Sara Gandini, Gibran Horemheb Rubio Quintanares, Ana Abecasis, Pier Luigi Lopalco, Oriana D'Ecclesiis, Susanna Chiocca, Elisa Tomezzoli, Ilaria Cutica, Davide Mazzoni and 11 more

Erratum issued Registry-linked trialOpen access · goldAbstract readClinical Trial Protocol
In one paragraph

Article in BMC infectious diseases, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. It is linked to trial NCT05396040 (School Studies Within the EuCARE Horizon Europe Research Project), which is not on this map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
6.0field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT05396040 nacompletednot on this map

School Studies Within the EuCARE Horizon Europe Research Project (EUCARE-SCHOOLS Study)

TypeinterventionalSponsorEuresist Network GEIERan2022 to 2024Enrolled3,373ConditionsSTUDENTSArmsLOLLI METHODE
3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 19 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

21 authors at 6 institutions in 5 countries.

Sara Raimondi *Department of Experimental Oncology, IEO, European Institute of Oncology IRCCS, Milan, Italy.
Sara Gandini *Department of Experimental Oncology, IEO, European Institute of Oncology IRCCS, Milan, Italy.
Gibran Horemheb Rubio QuintanaresInstitute of Virology, University Clinics of Cologne, Cologne, Germany. gibran.rubio@pei.de.ORCID http://orcid.org/0000-0002-9529-9804
Ana AbecasisGlobal Health and Tropical Medicine, Institute of Hygiene and Tropical Medicine, New University of Lisbon, Lisbon, Portugal.
Pier Luigi LopalcoDepartment of Biological and Environmental Sciences and Technology, University of Salento, Lecce, Italy.
Oriana D'EcclesiisDepartment of Experimental Oncology, IEO, European Institute of Oncology IRCCS, Milan, Italy.
Susanna ChioccaDepartment of Experimental Oncology, IEO, European Institute of Oncology IRCCS, Milan, Italy.
Elisa TomezzoliApplied Research Division for Cognitive and Psychological Science, European Institute of Oncology (IEO), IRCCS, Milan, Italy.
Ilaria CuticaDepartment of Oncology and Hemato-Oncology, University of Milan, Milan, Italy.
Davide MazzoniDepartment of Oncology and Hemato-Oncology, University of Milan, Milan, Italy.
Nuno AmparoGlobal Health and Tropical Medicine, Institute of Hygiene and Tropical Medicine, New University of Lisbon, Lisbon, Portugal.
Marta PingarilhoGlobal Health and Tropical Medicine, Institute of Hygiene and Tropical Medicine, New University of Lisbon, Lisbon, Portugal.
Daniela CarmagnolaDepartment of Biomedical, Surgical and Dental Sciences, University of Milan, Milan, Italy.
Claudia DellaviaDepartment of Biomedical, Surgical and Dental Sciences, University of Milan, Milan, Italy.
Gianvincenzo ZuccottiPediatric Department, "Vittore Buzzi" Children's Hospital, Milan, Italy.
Chiara RonchiniDepartment of Experimental Oncology, IEO, European Institute of Oncology IRCCS, Milan, Italy.
Federica BellerbaDepartment of Experimental Oncology, IEO, European Institute of Oncology IRCCS, Milan, Italy.
Felix DewaldInstitute of Virology, University Clinics of Cologne, Cologne, Germany.
Rolf Kaiser *Institute of Virology, University Clinics of Cologne, Cologne, Germany.
Francesca Incardona *IPRO-InformaPRO S.R.L., Rome, Italy.
Eucare WP4
European Institute of Oncology · ITUniversity of Milan · ITUniversity of Lisbon · PTInforma (Italy) · ITUniversity of Cologne · DEUniversity of Salento · IT

Funding

European Commission 101046016
6 · The paper itself

Abstract

backgroundContradictory results were reported on the role of school closure/reopening on the overall SARS-CoV-2 transmission rate, as well as on which kind and level of mitigation measures implemented in schools may be effective in limiting its diffusion. Some recent studies were reassuring, showing that opening did not increase the community spread, although teachers and families are worried about the high class density. On the other hand, distance learning was associated with a negative impact on learning, sociability and psychological health, especially in vulnerable children. As it becomes clear that the SARS-CoV-2 pandemic will last for a long time, there is a high need for studies and solutions to support safe schools opening based on scientific evidence of harms and benefits. The Lolli-Methode (LM) is a strategy for epidemiological surveillance and early intervention aiming at SARS-CoV-2 outbreaks' reduction in schools, relying on polymerase chain reaction analysis of saliva samples.

methodsIn this cluster randomised trial protocol, we aim to determine whether the LM is useful to support schools opening and to reduce clusters and attack rates in schools, compared with the standard of care (SoC) surveillance by public health departments. This multicenter study will enrol 440 classes (around 8800 students, teachers and other personnel) from two countries, cluster randomised to LM or SoC. The samples from the pools will be collected and tested using PCR-based techniques. Test results will be combined with questionnaires filled in by children, parents, schoolteachers, and principals, concerning ongoing mitigation measures, their perceived psychological impact and other health and socio-economic information. An ancillary observational study will be carried out to study the prevalence of SARS-CoV-2 in schools, frequencies and size of clusters and attack rates, to compare the effectiveness of the different preventive measures adopted and to evaluate psychological issues in students and teachers in relation to the pandemic's containment measures. DISCUSSION: By the end of this study, we will have defined and characterised the applicability of the LM for SARS-CoV-2 surveillance, as well as the impact of pandemic preventive measures on children and teachers. Trial registration International Standard Randomised Controlled Trial Number: NCT05396040, 27.05.2022.

Indexed as

COVID-19ChildDisease OutbreaksHumansMulticenter Studies as TopicObservational Studies as TopicPandemicsRandomized Controlled Trials as TopicSARS-CoV-2SchoolsAdolescents’ healthChildren’s healthCOVID-19PandemicSchools

Identifiers

PMID36597074
PMCPMC9808677
OpenAlexW4313439081

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.